Compounds > norgestrel

norgestrel and Vascular Diseases

norgestrel has been researched along with Vascular Diseases in 4 studies

Research

Studies (4)

TimeframeStudies, this research(%)All Research%
pre-19904 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Basdevant, A; Conard, J; Corvol, P; Elkik, F; Guy-grand, B1
Dabholkar, NA; Rane, VA1

Other Studies

4 other study(ies) available for norgestrel and Vascular Diseases

ArticleYear
Sixth fertility and sterility congress--a review.
    IPPF medical bulletin, 1968, Volume: 2, Issue:3

    Topics: Biology; Chlormadinone Acetate; Clomiphene; Contraception; Contraceptive Agents; Contraceptive Agents, Female; Contraceptives, Oral; Contraceptives, Oral, Combined; Contraceptives, Oral, Hormonal; Copper; Disease; Embolism; Endocrine System; Estrogens; Evaluation Studies as Topic; Family Planning Services; Hormones; Incidence; Infections; Injections; Intrauterine Devices; Medroxyprogesterone Acetate; Menstruation Disturbances; Norgestrel; Pelvic Inflammatory Disease; Physiology; Progesterone Congeners; Quinestrol; Research; Research Design; Therapeutics; Thromboembolism; Time; Uterine Perforation; Vascular Diseases; Zinc

1968
[Vaginal ring contraception in hypertensive women].
    Contraception, fertilite, sexualite, 1985, Volume: 13, Issue:1 Suppl

    Topics: Biology; Blood Pressure; Cardiovascular System; Cerebrovascular Circulation; Contraception; Contraceptive Agents; Contraceptive Agents, Female; Contraceptive Devices, Female; Contraceptives, Oral; Disease; Endocrine System; Estradiol; Estrogens; Family Planning Services; Hormones; Hypertension; Norgestrel; Physiology; Reproductive Control Agents; Vascular Diseases

1985
Effect of short term use of oral contraceptives on fibrinolytic activity of the blood.
    Current medical practice, 1973, Volume: 17, Issue:5

    Topics: Biology; Blood; Blood Coagulation; Contraception; Contraceptive Agents; Contraceptive Agents, Female; Contraceptives, Oral; Contraceptives, Oral, Combined; Contraceptives, Oral, Hormonal; Disease; Embolism; Ethinyl Estradiol; Family Planning Services; Fibrinolysis; Norgestrel; Physiology; Research; Thromboembolism; Thrombosis; Vascular Diseases

1973
Norgestrel, increased lipids: fact or "marketing monster"?
    Contraceptive technology update, 1989, Volume: 10, Issue:10

    Topics: Americas; Arterial Occlusive Diseases; Arteriosclerosis; Biology; Contraception; Contraceptive Agents; Contraceptive Agents, Female; Contraceptives, Oral; Contraceptives, Oral, Combined; Contraceptives, Oral, Hormonal; Developed Countries; Disease; Ethinyl Estradiol; Family Planning Services; Levonorgestrel; Lipids; Norethindrone; Norgestrel; North America; Physiology; United States; Vascular Diseases

1989